Retroviral vectors for use in human gene therapy for cancer, Gaucher disease, and arthritis.
Robbins
P D
PD
Department of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine, Pennsylvania 15261.
Tahara
H
H
Mueller
G
G
Hung
G
G
Bahnson
A
A
Zitvogel
L
L
Galea-Lauri
J
J
Ohashi
T
T
Patrene
K
K
Boggs
S S
SS
D000818:Animals; D001172:Arthritis, Rheumatoid / Q000628:therapy*; D005776:Gaucher Disease / Q000235:genetics / Q000628:therapy*; D015316:Genetic Therapy; D005822:Genetic Vectors; D005962:Glucosylceramidase / Q000235:genetics; D006801:Humans; D007167:Immunotherapy; D053590:Interleukin 1 Receptor Antagonist Protein; D018664:Interleukin-12; D007378:Interleukins / Q000008:administration & dosage; D008546:Melanoma, Experimental / Q000628:therapy*; D051379:Mice; D012190:Retroviridae / Q000235:genetics*; D012795:Sialoglycoproteins / Q000235:genetics; D016019:Survival Analysis
C507763:IL1RN protein, human; C507764:Il1rn protein, mouse; D053590:Interleukin 1 Receptor Antagonist Protein; D007378:Interleukins; D012795:Sialoglycoproteins; D018664:Interleukin-12; D005962:Glucosylceramidase